The autoimmune process in rheumatoid arthritis depends on activation of immune cells, which utilize intracellular kinases to respond to external stimuli such as cytokines, immune complexes, and antigens. CD4+ T cells comprise a large proportion of the inflammatory cells that invade the synovial tissue and may therefore be a cell type of pathogenic importance. Both methotrexate and infliximab are effective in the treatment of inflammatory arthritis; however, the biological effects triggered by these treatments and the biochemical mechanisms underlining the cell response are still not fully understood. Thus, in this study the global metabolic changes associated with methotrexate or infliximab treatment of isolated human CD4+ T cells were examined using gas chromatography/mass spectrometry or liquid chromatography/mass spectrometry. In total 148 metabolites involved in selective pathways were found to be significantly altered. Overall, the changes observed are likely to reflect the effort of CD4+ cells to increase the production of cellular reducing power to offset the cellular stress exerted by treatment. Importantly, analysis of the global metabolic changes associated with MTX or infliximab treatment of isolated human CD4+ T cells suggested that the toxicity associated with these agents is minimal when used at clinically relevant concentrations.

Chimenti, M.s., Tucci, P., Candi, E., Perricone, R., Melino, G., Willis, A. (2013). Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab. CELL CYCLE, 12(18), 3025-3036 [10.4161/cc.26067].

Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab

CHIMENTI, MARIA SOLE;TUCCI, PAOLA;CANDI, ELEONORA;PERRICONE, ROBERTO;MELINO, GENNARO;
2013-01-01

Abstract

The autoimmune process in rheumatoid arthritis depends on activation of immune cells, which utilize intracellular kinases to respond to external stimuli such as cytokines, immune complexes, and antigens. CD4+ T cells comprise a large proportion of the inflammatory cells that invade the synovial tissue and may therefore be a cell type of pathogenic importance. Both methotrexate and infliximab are effective in the treatment of inflammatory arthritis; however, the biological effects triggered by these treatments and the biochemical mechanisms underlining the cell response are still not fully understood. Thus, in this study the global metabolic changes associated with methotrexate or infliximab treatment of isolated human CD4+ T cells were examined using gas chromatography/mass spectrometry or liquid chromatography/mass spectrometry. In total 148 metabolites involved in selective pathways were found to be significantly altered. Overall, the changes observed are likely to reflect the effort of CD4+ cells to increase the production of cellular reducing power to offset the cellular stress exerted by treatment. Importantly, analysis of the global metabolic changes associated with MTX or infliximab treatment of isolated human CD4+ T cells suggested that the toxicity associated with these agents is minimal when used at clinically relevant concentrations.
2013
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
English
Con Impact Factor ISI
Chimenti, M.s., Tucci, P., Candi, E., Perricone, R., Melino, G., Willis, A. (2013). Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab. CELL CYCLE, 12(18), 3025-3036 [10.4161/cc.26067].
Chimenti, Ms; Tucci, P; Candi, E; Perricone, R; Melino, G; Willis, A
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Metabolic profiling of human CD4+ cells.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 3.98 MB
Formato Adobe PDF
3.98 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/86769
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 18
social impact